Y-Intercept (HK)’s RAPT Therapeutics RAPT Stock Holding History

Y-Intercept (HK)’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,237	Closed	-$381K	–	1964
2025 Q4	$381K	Buy	+11,237	New	+$349K	0.01%	1313

Y-Intercept (HK)'s RAPT Position: Q1 2026 in Review

Y-Intercept (HK) sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 11,237 shares — an estimated $381K sold.

Y-Intercept (HK) first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $381K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Y-Intercept (HK) reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 11,237 RAPT Therapeutics shares in Q1 2026, an estimated $381K.
Y-Intercept (HK) first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Y-Intercept (HK)'s RAPT Therapeutics position peaked at $381K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.